PREPARATION OF RAT-BRAIN MEMBRANES HIGHLY ENRICHED WITH OPIATE KAPPA BINDING-SITES USING SITE-DIRECTED ACYLATING AGENTS - OPTIMIZATION OF ASSAY CONDITIONS

被引：38

作者：

ROTHMAN, RB

BYKOV, V

DANKS, JA

JACOBSON, AE

BURKE, TR

RICE, KC

HERKENHAM, M

机构：

[1] NIMH,NEUROPHYSIOL LAB,BETHESDA,MD 20205

[2] ST ELIZABETHS HOSP,NIMH,OVERHOLLSER DIV TRAINING,WASHINGTON,DC 20032

[3] NIADDK,CHEM LAB,BETHESDA,MD 20205

来源：

NEUROPEPTIDES | 1985年 / 6卷 / 06期

关键词：

D O I：

10.1016/0143-4179(85)90112-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：503 / 516

页数：14

共 23 条

[1] INTERCONVERTING MU-FORMS AND DELTA-FORMS OF THE OPIATE RECEPTOR IN RAT STRIATAL PATCHES
BOWEN, WD
GENTLEMAN, S
HERKENHAM, M
PERT, CB
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08): : 4818 - 4822
[2] DYNORPHIN1-8 AND DYNORPHIN1-9 ARE LIGANDS FOR THE KAPPA-SUBTYPE OF OPIATE RECEPTOR
CORBETT, AD
PATERSON, SJ
MCKNIGHT, AT
MAGNAN, J
KOSTERLITZ, HW
[J]. NATURE, 1982, 299 (5878) : 79 - 81
[3] K-OPIATE RECEPTORS LOCALIZED BY AUTORADIOGRAPHY TO DEEP LAYERS OF CEREBRAL-CORTEX - RELATION TO SEDATIVE EFFECTS
GOODMAN, RR
SNYDER, SH
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (18): : 5703 - 5707
[4] HERKENHAM M, 1982, J NEUROSCI, V2, P1129
[5] SOLUBILIZATION AND CHARACTERIZATION OF MU-OPIOID, DELTA-OPIOID, AND KAPPA-OPIOID BINDING-SITES FROM GUINEA-PIG BRAIN - PHYSICAL SEPARATION OF KAPPA-RECEPTORS
ITZHAK, Y
HILLER, JM
SIMON, EJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (13): : 4217 - 4221
[6] A PROTEIN-LIPID MODEL OF THE OPIATE RECEPTOR
LEE, NM
SMITH, AP
[J]. LIFE SCIENCES, 1980, 26 (18) : 1459 - 1464
[7] [H-3]-LABELED SUFENTANIL, A SUPERIOR LIGAND FOR MU-OPIATE RECEPTORS - BINDING-PROPERTIES AND REGIONAL DISTRIBUTION IN RAT-BRAIN AND SPINAL-CORD
LEYSEN, JE
GOMMEREN, W
NIEMEGEERS, CJE
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 87 (2-3) : 209 - 225
[8] MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517
[9] MCKNIGHT AT, 1984, NEUROPEPTIDES, V5, P97, DOI 10.1016/0143-4179(84)90036-2
[10] PERT CB, 1974, MOL PHARMACOL, V10, P868

← 1 2 3 →